KITLG and cancer: The selective expression of KITLG by bTAM is intriguing in view of its function as a stemness-promoting factor and the previous identification of its receptor CD133 as a marker for ovarian epithelial stem cells in the mouse (92) and for cancer stem cells in ascites (93, 94).